$FFIV

OKEKE ANGELIQUE M sold $208K of FFIV

OKEKE ANGELIQUE M (EVP, General Counsel) sold 515 shares of F5, INC. (FFIV) at $404.49 ($0.21M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · OKEKE ANGELIQUE M
Published Aug 4, 2026, 9:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 9:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FFIV
Neutral
medium confidence
Mentioned
$FFIV
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FFIVNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings by the company’s EVP and General Counsel, executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 plan suggests limited actionable information about near-term fundamentals.

03

What to watch

The article provides only the sale details, not any offsetting purchases or broader insider activity trends, limiting signal strength.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-04 after-hours; transaction dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for F5, Inc. (FFIV).

Company-level read

Ticker impact

$FFIVNeutralMedium confidence
Context

F5 disclosed an insider open-market sale by its EVP and General Counsel of 515 shares at $404.4946 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicit pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary sales.

Market effects

Minimal, as the disclosure is company-specific and not a sector-wide regulatory or operational event.

None indicated.

None indicated.

Counterpoint

Insider sales can still coincide with private information, but the 10b5-1 structure makes that inference weaker.

Key entities

  • F5, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • OKEKE ANGELIQUE M

    EVP and General Counsel who sold 515 shares under a 10b5-1 plan.

Related articles

$FFIVMed

5 Revealing Analyst Questions From F5’s Q2 Earnings Call

F5 reported Q2 results above Wall Street expectations, with revenue of $865.1M vs $835M estimates and adjusted EPS of $4.73 vs $4.00. Management cited 19% product revenue growth and demand for application security and delivery. Q3 guidance midpoint revenue is $880M and full-year adjusted EPS guidance is $17.27. Analysts questioned AI-driven growth, hardware refresh, and sustainability.